Gene & Cell Therapy
Focusing on
cutting-edge genetic and
cellular approaches, this session will explore gene editing, adoptive cell
transfer, and stem cell-based cancer therapies. Experts
will discuss the application of CRISPR-Cas9, viral vectors,
and non-viral systems for tumour-specific gene
modifications.
Clinical updates on
CAR-T and CAR-NK therapies will be presented, along with strategies to overcome
immune evasion and tumour heterogeneity. Ethical and regulatory frameworks for gene and
cell therapies will also be addressed. Real-world patient experiences and trial
data will underpin discussions.
Subtracks:
- CRISPR, TALEN, and Gene Editing in Oncology
- Viral and Non-Viral Gene Delivery Systems
- CAR-T and CAR-NK Cell Therapy Advances
- Stem Cell-Based Therapeutics
- Regulatory and Ethical Considerations
- Overcoming Immune Escape in Solid Tumours